Browsing Tag

swiperx

close-up-drugs-medical-163944

In Southeast Asia, patients aren’t finishing their TB medications. Why?

There are many reasons why patients in Southeast Asia do not take their full courses of TB medications. This non-adherence causes multi-drug resistant strains of TB (MDR-TB), which poses a deadly threat to health worldwide. We must improve TB treatment adherence in Southeast Asia, where MDR-TB is rising. In order to do that, we need to understand the barriers to treatment that patients face, which include: 1) Lack of knowledge and misinformation about treatment When a TB patient undergoes treatment, they will start to feel better just a few weeks after starting treatment. Oftentimes, when this happens the patient wrongfully assumes that their TB is

What insights will big data provide on public health?

While most developed countries are using electronic prescriptions and health records that generate big data insights, there has been far less use of these technologies in emerging regions like Southeast Asia. Southeast Asia has the highest proportion of global mortality, with an overly large share of tuberculosis, maternal conditions, child mortality, and injuries. There is clearly a dire need for improvements in public health information infrastructure. Big data has the capability to plug this “healthcare gap” by boosting quality and access to care at a reduced cost. mClinica’s SwipeRx platform is already leading the way by connecting over 100,000 pharmacies

Why Pharmacists Are Critical To Primary Care In Southeast Asia

Pharmacists are critical to primary care. They are often the first point of access to healthcare because they are easily accessible to the public: they are often available 24 hours a day, protect confidentiality, do not require scheduling an appointment, and do not charge consultation fees. In fact, according to a 2005 study, individuals who live in regions with high numbers of primary care providers, like pharmacists, have better health outcomes than those who do not. However, pharmacists in developing regions like Southeast Asia are not being utilized to their full potential because their place in healthcare is not yet established. Therefore,